Acute recurrent pericarditis: from pathophysiology towards new treatment strategy

This article reviews current guidelines and notes growing evidence to suggest a place for IL-1 receptor antagonists, including a randomised placebo-controlled study of anakinra. Their position in the treatment algorithm however requires further evaluation.

Heart